Study Medicaid breast pump reimbursement impact

Summary#

Louisiana Senate Resolution 175 (SR 175) is an enrolled Senate resolution, not a bill that amends Medicaid law. It asks the Louisiana Department of Health (LDH) to study the effects of raising Medicaid breast-pump reimbursement and coverage from $80 to $140; its stated goal is to improve access to medically necessary breastfeeding equipment.

  • LDH is asked to study current use and access, other states’ reimbursement rates, supplier participation, possible health outcomes, fiscal effects and possible savings, and options for legislative or administrative action.
  • The resolution says the study must include those topics and that LDH must send a written report to the Senate Committee on Health and Welfare by February 1, 2027.
  • It does not itself raise the reimbursement or coverage amount, change who qualifies, or create a new patient benefit.

What it means for you#

  • Medicaid recipients: The resolution does not change your breast-pump coverage or reimbursement. The $80 and $140 amounts are the subject of the proposed study, not a change made by this resolution.
  • Louisiana Department of Health: LDH is asked to conduct the study and submit the report by the stated deadline. The resolution does not set a study method or require LDH to adopt any recommendations.
  • Legislators: The report is intended to inform consideration of legislative or administrative action. The resolution does not require them to take further action.

Money#

The resolution requires a study and report, but provides no cost estimate or funding source.

  • It asks LDH to examine possible costs and savings from increased access; it does not establish that savings would occur.
  • The resolution specifies no appropriation, new fee, or payment to patients or suppliers.

What is unclear#

  • The supplied materials do not include current Medicaid rules, so the stated $80 amount and the current coverage process cannot be verified against those rules.
  • The resolution does not explain how LDH should conduct the study, or whether patients, suppliers, or other groups must be consulted.
  • It does not define how “coverage” differs from “reimbursement” in the proposed $80-to-$140 change.
  • It does not say whether, or when, any study recommendation would be put into effect.

Case for#

  • A study could give lawmakers information about whether the current amount affects access, supplier participation, or patient choice.
  • Comparing rates in other states and examining health and fiscal effects could help assess a possible increase before deciding whether to make one.
  • The report deadline gives the Senate committee a set date to receive findings and recommendations.

Case against#

  • The resolution does not raise the amount now, so it does not itself address any access barriers while the study is underway.
  • It does not require LDH or the legislature to act on the report’s recommendations.
  • The resolution does not set a method for measuring health outcomes, costs, or supplier participation, which could leave the study’s conclusions dependent on choices LDH makes.